|Dipali Trivedi, MD||Thomas Dvorak, MD|
|Mickey Liao, MD||Patrick Kelly, MD|
|Rafael Manon, MD|
|Akash Nanda, MD, PhD|
Justin M. Rineer, MD
Dipali Trivedi, MD is board certified in internal medicine and medical oncology. She specializes in general hematology and oncology for MD Anderson - Orlando. Dr. Trivedi, a native Floridian, received her bachelor's degree from Emory University and her MD from New York Medical College. She completed her internship, residency, and fellowship at Emory University School of Medicine. She also served on the Emory faculty as an Instructor in internal medicine at Winship Cancer Institute / Grady Memorial Hospital from 2007-2008. She completed her fellowship in 2011, after which she was an attending physician at the Tampa VA Hospital, an affiliate of the University of South Florida.
Dr. Trivedi has a great deal of experience in benign and malignant hematology as well as breast cancer. During her fellowship, she served as clinical supervisor of the Grady Sickle Cell Acute Care Center. She has worked in the basic science laboratory on both on platelet functionality as well as drug-resistance in breast cancer cell lines. She also received a Medical Student Teaching Award in 2007 and served on the internal medicine residency class representative committee at Grady Memorial Hospital. She has been awarded the Lynn Sage Breast Cancer Achievement Award in 2010 and has participated in numerous research fairs during her years in training. She has published work in Current Breast Cancer Reports pertaining to breast cancer hormone resistance in metastatic disease and attended the School of Breast Oncology conference in 2010. Dr. Trivedi is a member of the American Medical Association, the American Society of Clinical Oncology, and the American Society of Hematology.
Mickey Liao, MD, graduated from Pennsylvania State University with a Bachelor of Science degree and from the Thomas Jefferson University Jefferson Medical College in Philadelphia with a doctorate in medicine. He then studied at the University of California, Los Angeles (UCLA) in a graduate program, a clinical investigation, and for ethics in patient-oriented research.
After finishing school, Dr. Liao completed his sophomore fellowship at Thomas Jefferson University. He did his internship and residency at the University of Illinois and was the chief medical resident at the Jesse Brown Veterans Affairs Medical Center. Dr. Liao then completed a geriatric medicine fellowship as well as a hematology and oncology fellowship at UCLA. While at the University of Illinois, he was awarded The Gold Foundation Humanism and Excellence in Teaching Award and the AOA Clinical Teaching Award.
Dr. Liao is an associate member of the American Society of Hematology and American Society of Clinical Oncology. He is fluent in entry level Taiwanese and Mandarin.
Dr. Dvorak serves as a radiation oncologist at MD Anderson Cancer Center Orlando. He specializes in the treatment of breast and gynecological cancers.
Dr. Dvorak received his medical degree from Columbia University College of Physicians and Surgeons. He completed his internship in Internal Medicine at Harvard University/Mt. Auburn Hospital. He completed his clinical research fellowship in radiation oncology at Mahidol University/Siriraj Hospital.
Prior to focusing on radiation oncology, Dr. Dvorak served as a healthcare consultant with Easton Associates, where he led evaluations of new drugs, medical devices and health technology for venture capital firms, biotechnology companies and pharmaceutical companies. Before joining MD Anderson - Orlando, Dr. Dvorak served as chief resident in the department of radiation oncology at Tufts University/Tufts Medical Center as well as at Brown University/Rhode Island Hospital. His research interests include health technology assessment with a focus on potential utilization of proton therapy and evidence-driven delivery of medical care.
His research has been published in peer-reviewed journals. He also works as a developer and editor of the online Wiki Textbook of Radiation Oncology. He is currently a member of the American Brachytherapy Society, American Society of Clinical Oncology, the American Medical Association and the American Society for Radiation Oncology, where he serves on the Communications Committee.
Patrick Kelly, MD, PhD, graduated summa cum laude with his bachelor's degree from the University of Notre Dame in 1999. In 2007, he graduated with his doctoral degree from the School of Medicine/Department of Pharmacology at Duke University. He completed his internship at the University of Florida Department of Medicine in 2008.
In 2005, Dr. Kelly won the Experimental Biology/IUPS Travel Award and the AAAS/Science Program for Excellence in Science nomination. In 2006, he was awarded the Duke Cancer Center Intramural Research Award. During his tenure at Duke, he was awarded the Duke Medical Alumni MD/PhD Training Grant.
He is adept in several clinical skills, including GammaKnife-based intracranial stereotactic radiosurgery, proton therapy for pediatric cancers, and stereotactic body radiotherapy for lung cancer and spinal metastases.
Dr. Kelly is on the editorial board and reviews the International Journal of Radiation Oncology * Biology * Physics. He has nearly two dozen published articles and has presented at several national conferences, including the Gordon Research Conference, the American Society for Radiation Oncology (ASTRO) Annual Meeting, the American Society for Therapeutic Radiology Oncology, and the American Radium Society.
Dr. Manon, MD, is board certified in radiation oncology and serves as a radiation oncologist for MD Anderson Cancer Center Orlando.
He received his medical degree from the University of Florida College of Medicine. He completed a residency in radiation oncology at the University of Wisconsin (UW) Hospital and Clinics, where he served as chief resident. Dr. Mañon completed an internship in internal medicine at Jackson Memorial Hospital in Miami and earned a medical degree from the University of Florida. At UW, he served as the chief resident of radiation oncology during his final year and as an instructor in radiotherapy technology.
Dr. Mañon brings a wealth of experience in helical tomotherapy to MD Anderson - Orlando. Through the University of Wisconsin, where tomotherapy was created, he is researching and developing more aggressive treatments for cancer, with the aim of improving cancer cure rates while maintaining a clinically acceptable level of side effects.
Dr. Mañon received the Outstanding Achievement in Science, Engineering and Mathematics Award from the Office of Naval Research.
Additionally, Dr. Mañon has published several peer-reviewed articles in medical journals including the Journal of Clinical Oncology, Radiotherapy and Oncology and International Journal of Radiation Oncology Biology and Physics. His professional affiliations include the American Society of Clinical Oncology, the American Society of Therapeutic Radiology and Oncology and the Radiation Therapy Oncology Group. He has faculty appointments at the University of Central Florida, Florida State University and The University of Texas MD Anderson Cancer Center in Houston. He is fluent in Spanish and Portuguese and has many interests including martial arts.
Akash Nanda, MD, PhD, is board certified in radiation oncology with subspecialties in urology and hematology. He serves as director of genitourinary and hematologic radiation oncology at MD Anderson - Orlando and director of radiation oncology at Dr. P. Phillips Hospital and Health Central Hospital. He is an assistant professor at the University of Central Florida College of Medicine and adjunct professor at The University of Texas MD Anderson Cancer Center, teaching radiation oncology. Dr. Nanda graduated from the combined MD/PhD program at The Johns Hopkins University School of Medicine, where he also received his doctorate degree in human genetics and molecular biology. He completed his residency in radiation oncology at the Harvard Radiation Oncology Program, receiving a resident research grant from the Radiologic Society of North America (RSNA). He was selected by the American Brachytherapy Society to participate as a prostate brachytherapy fellow at the Seattle Prostate Institute.
Dr. Nanda's primary research interests include outcomes analyses and the design of prospective clinical trials for men with prostate and bladder cancer. He is also interested in developing and testing new technologies aimed at improving the precision of radiation treatment delivery and has one patented biomedical invention. Dr. Nanda has presented his research findings at several national meetings, including the American Society for Radiation Oncology (ASTRO), American Society of Clinical Oncology (ASCO) and American Association for Cancer Research (AACR). He also has numerous publications in peer-reviewed journals, including the Journal of the American Medical Association, Journal of Clinical Oncology and International Journal of Radiation Oncology*Biology*Physics.
He is currently a member of ASTRO, ASCO, RSNA, AACR and the American Medical Association.
Dr. Rineer serves as a radiation oncologist physician for the Radiation Oncology Specialty Section at MD Anderson Cancer Center Orlando. He specializes in melanoma/sarcoma and thoracic malignancies.
Dr. Rineer graduated magna cum laude with his medical degree from State University of New York - Downstate, where he also completed his residency in radiation oncology and served as chief resident. During his residency, he became a recipient of the 2008 and 2009 American Society of Clinical Oncology (ASCO) Foundation Award for original research presented at the ASCO annual meeting. He was an advanced radiation oncology fellow at The University of Texas MD Anderson Cancer Center in Houston where he gained extensive experience in applying advanced technologies to lung cancer and other thoracic malignancies.
Dr. Rineer's primary research interests include improving outcomes through the application of multi-modality treatment in lung and esophagheal cancer. He has presented his original research at top national and international meetings, including the annual meetings of the American Society of Radiation Oncology, the Canadian Association of Radiation Oncology and the American Society of Clinical Oncology. Dr. Rineer has also published several peer-reviewed articles in high-impact journals such as Chest, Cancer, Radiotherapy and Oncology and the Journal of Thoracic Oncology.
He is currently a member of the American Society of Clinical Oncology and the American Society of Radiation Oncology.
© 2012 Health Central Hospital. All rights reserved.